<PAGE>
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------
Amendment No. 1 to
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
ALGOS PHARMACEUTICAL CORPORATION
- --------------------------------------------------------------------------------
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
DELAWARE 22-3142274
---------------------------------------- --------------
(STATE OF INCORPORATION OR ORGANIZATION) (IRS EMPLOYER
IDENTIFICATION NO.)
4900 ROUTE 33, COLLINGWOOD PLAZA; NEPTUNE, NEW JERSEY 07753
----------------------------------------------------- ----------
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
If this Form relates to the If this Form relates to the
registration of a class of debt registration of a class of debt
securities and is effective upon filing securities and is to become effective
pursuant to General simultaneously with the
Instruction A(c)(1) please check the effectiveness of a concurrent
following box. [ ] registration statement under the
Securities Act of 1933 pursuant to
General Instruction A(c)(2) please
check the following box. [ ]
Securities to be registered pursuant to Section 12(b) of the Act:
TITLE OF EACH CLASS NAME OF EACH EXCHANGE ON WHICH
TO BE SO REGISTERED EACH CLASS IS TO BE REGISTERED
------------------- ------------------------------
- ----------------------------------- -------------------------------------
- ----------------------------------- -------------------------------------
Securities to be registered pursuant to Section 12(g) of the Act:
COMMON STOCK, $.01 PAR VALUE
- --------------------------------------------------------------------------------
(TITLE OF CLASS)
- --------------------------------------------------------------------------------
(TITLE OF CLASS)
<PAGE>
<PAGE>
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
For a description of the common stock, $.01 par value per share
(the "Common Stock") of the Registrant, see the information under the caption
"Description of Capital Stock" in the Registration Statement on Form S-1 (File
No. 333-04313) of the Registrant (the "Registration Statement"), which
description is hereby incorporated by reference herein. In addition, any
prospectus contained in the Registration Statement that is filed pursuant to
Rule 424(b) under the Securities Act of 1933 shall be deemed incorporated by
reference herein. Application has been made to list the Common Stock on the
Nasdaq National Market.
ITEM 2. EXHIBITS.
Exhibit No. Description
- ----------------- ---------------------------------------------------------
4.1 Certificate of Incorporation of the Registrant
(incorporated by reference to Exhibit No. 3.1 of the
Registration Statement)
4.2 Bylaws of the Registrant (incorporated by reference to
Exhibit No. 3.2 of the Registration Statement)
4.3 Algos Pharmaceutical Corporation Stockholders Agreement
(incorporated by reference to Exhibit No. 10.3.1 of the
Registration Statement)
5.1 Specimen certificate of common stock (incorporated by
reference to Exhibit No. 4.1 of the Registration
Statement)
2
<PAGE>
<PAGE>
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereto duly authorized.
/s/ John W. Lyle
------------------------------------
John W. Lyle
President and Chief Executive Officer
September 25, 1996
3
